Literature DB >> 15163211

2-aminopyridines as highly selective inducible nitric oxide synthase inhibitors. Differential binding modes dependent on nitrogen substitution.

Stephen Connolly1, Anders Aberg, Andrew Arvai, Haydn G Beaton, David R Cheshire, Anthony R Cook, Sally Cooper, David Cox, Peter Hamley, Phil Mallinder, Ian Millichip, David J Nicholls, Robin J Rosenfeld, Stephen A St-Gallay, John Tainer, Alan C Tinker, Alan V Wallace.   

Abstract

4-Methylaminopyridine (4-MAP) (5) is a potent but nonselective nitric oxide synthase (NOS) inhibitor. While simple N-methylation in this series results in poor activity, more elaborate N-substitution such as with 4-piperidine carbamate or amide results in potent and selective inducible NOS inhibition. Evidently, a flipping of the pyridine ring between these new inhibitors allows the piperidine to interact with different residues and confer excellent selectivity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163211     DOI: 10.1021/jm031035n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Nitric-oxide synthase forms N-NO-pterin and S-NO-cys: implications for activity, allostery, and regulation.

Authors:  Robin J Rosenfeld; Joseph Bonaventura; Blair R Szymczyna; Michael J MacCoss; Andrew S Arvai; John R Yates; John A Tainer; Elizabeth D Getzoff
Journal:  J Biol Chem       Date:  2010-07-21       Impact factor: 5.157

Review 2.  Inducible nitric oxide synthase: Regulation, structure, and inhibition.

Authors:  Maris A Cinelli; Ha T Do; Galen P Miley; Richard B Silverman
Journal:  Med Res Rev       Date:  2019-06-13       Impact factor: 12.944

Review 3.  Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

Authors:  Paramita Mukherjee; Maris A Cinelli; Soosung Kang; Richard B Silverman
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

4.  Potent reversible inhibition of myeloperoxidase by aromatic hydroxamates.

Authors:  Louisa V Forbes; Tove Sjögren; Françoise Auchère; David W Jenkins; Bob Thong; David Laughton; Paul Hemsley; Garry Pairaudeau; Rufus Turner; Håkan Eriksson; John F Unitt; Anthony J Kettle
Journal:  J Biol Chem       Date:  2013-11-05       Impact factor: 5.157

5.  Design and synthesis of 2-amino-4-methylpyridine analogues as inhibitors for inducible nitric oxide synthase and in vivo evaluation of [18F]6-(2-fluoropropyl)-4-methyl-pyridin-2-amine as a potential PET tracer for inducible nitric oxide synthase.

Authors:  Dong Zhou; Hsiaoju Lee; Justin M Rothfuss; Delphine L Chen; Datta E Ponde; Michael J Welch; Robert H Mach
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

6.  Design of benzene-1,2-diamines as selective inducible nitric oxide synthase inhibitors: a combined de novo design and docking analysis.

Authors:  Sandrea M Francis; Amit Mittal; Manishika Sharma; Prasad V Bharatam
Journal:  J Mol Model       Date:  2008-01-12       Impact factor: 1.810

7.  Food-related compounds that modulate expression of inducible nitric oxide synthase may act as its inhibitors.

Authors:  Wilson Maldonado-Rojas; Jesus Olivero-Verbel
Journal:  Molecules       Date:  2012-07-05       Impact factor: 4.411

8.  Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.

Authors:  Elsa D Garcin; Andrew S Arvai; Robin J Rosenfeld; Matt D Kroeger; Brian R Crane; Gunilla Andersson; Glen Andrews; Peter J Hamley; Philip R Mallinder; David J Nicholls; Stephen A St-Gallay; Alan C Tinker; Nigel P Gensmantel; Antonio Mete; David R Cheshire; Stephen Connolly; Dennis J Stuehr; Anders Aberg; Alan V Wallace; John A Tainer; Elizabeth D Getzoff
Journal:  Nat Chem Biol       Date:  2008-10-12       Impact factor: 15.040

9.  Design and Synthesis of Imidazopyrimidine Derivatives as Potent iNOS Dimerization Inhibitors.

Authors:  Guo-Hua Chu; Bertrand Le Bourdonnec; Minghua Gu; Christopher W Ajello; Lara K Leister; Ian Sellitto; Joel A Cassel; Paul A Tuthill; Heather O' Hare; Robert N Dehaven; Roland E Dolle
Journal:  Open Med Chem J       Date:  2009-11-18

10.  Nitric Oxide Synthase Inhibitors into the Clinic at Last.

Authors:  Vu Thao-Vi Dao; Mahmoud H Elbatreek; Thomas Fuchß; Ulrich Grädler; Harald H H W Schmidt; Ajay M Shah; Alan Wallace; Richard Knowles
Journal:  Handb Exp Pharmacol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.